Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Shanghai Pharmaceuticals Holding Co ( (HK:2607) ).
Shanghai Pharmaceuticals Holding Co., Ltd. has announced a board meeting scheduled for March 27, 2025, to approve the company’s annual results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will determine the financial performance of the company and potentially impact its dividend distribution strategy, influencing stakeholders’ expectations and market positioning.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company based in the People’s Republic of China, operating in the pharmaceutical industry. The company focuses on the development, manufacturing, and distribution of pharmaceutical products and services.
YTD Price Performance: -5.83%
Average Trading Volume: 30,224
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $7.82B
For detailed information about 2607 stock, go to TipRanks’ Stock Analysis page.